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Abstract In mice, induced pluripotent stem (iPS)
cells with embryonic stem (ES)-like characteristics
have been derived by ectopic expression of four
transcription factors in somatic cells: Sox2, Oct3/4,
Klf4 and/or c-Myc. To date, iPS cells have only be
made from freshly harvested tissues and cells.
However, if iPS cells could be derived from frozen
tissues and cells, then cryopreservation of tissues
such as mouse tails could conceivably become a
reliable alternative to the more traditional formats,
like germplasm and ES cells, for the archiving of
genetically altered mouse lines. To test this hypoth-
esis, we sought to demonstrate that a live transgenic
mouse line could be recovered from transgenic iPS
cells derived from cryopreserved mouse tissues. Tails
and tail-derived ﬁbroblasts from a DsRED transgenic
mouse were cryopreserved in the presence of 5%
dimethylsulfoxide (DMSO) in liquid nitrogen for
1 week and 1 month, respectively. Afterward, tissues
and cells were thawed and underwent nuclear repro-
gramming by molecular transfection to derive iPS
cells which generated germline conﬁrmed transgenic
mice. Our results demonstrate for the ﬁrst time that
iPS cells can be efﬁciently derived from frozen-
stored-thawed tail tissue and ﬁbroblasts and used to
re-establish a transgenic mouse line. Therefore, this
study provides conclusive evidence that, as a
practical matter, frozen tails and ﬁbroblasts can be
used as an effective and reliable alternative to frozen
germplasm and ES cells for the storage, maintenance,
and distribution of genetically-altered mutant mice.
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Introduction
Until recently, it was thought that only embryonic
stem (ES) cells derived from the inner cell mass of
3.5 days post coitus (dpc) blastocysts retained sufﬁ-
cient pluripotency to propagate indeﬁnitely in vitro
(Evan and Kaufman 1981; Martin 1981) and undergo
targeted differentiation into a broad variety of cell
types (Rathjen and Rathjen 2001; Boheler et al.
2002). Now, however, it is well established that
induced pluripotent stem (iPS) cells with similar
characteristics to ES cells can be derived from adult
somatic cells by the introduction of four transcription
factors, namely Oct3/4, sox2, c-myc and Klf4
(Takahashi and Yamanaka 2006; Wernig et al.
2007). This method allows the production of ES-like
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ulate or destroy an embryo. Since these initial
achievements, we now know that a similar degree
of pluripotentiality can be attained using only three of
these transcription factors (Oct3/4, Sox2 and Klf4) by
omitting c-myc, which has been shown to induce
tumor formation in iPS cell-derived animals (Okita
et al. 2007; Nakagawa et al. 2007; Wernig et al.
2008). Using this modiﬁed reprogramming approach,
different somatic cell types, such as ﬁbroblasts,
hepatocytes and gastric epithelial cells, have been
shown to give rise to iPS cells efﬁciently (Takahashi
and Yamanaka 2006; Wernig et al. 2007; Aoi et al.
2008).
To date, iPS cells have been generated by the
reprogramming of cells isolated from freshly har-
vested tissues. There are numerous occasions when it
would be useful, if not essential, to be able to
effectively and reliably derive iPS cells from frozen-
thawed tissues. For example, snips of mouse tail that
are typically harvested to extract DNA for genotyping
by polymerase chain reaction (PCR) can be collected
and cryopreserved quickly and easily for storage. A
tail snip could then be thawed, ﬁbroblasts isolated,
and iPS cells derived for future research use. This
procedure has numerous applications. For operational
needs and other efﬁciencies, the ability to delay the
derivation of iPS cells using frozen tissues obviates
the need to pursue reprogramming of fresh cells
immediately after harvest. For example, lengthy
experimentation and/or invasive analysis may be
required to select the cohort of animals out of a larger
group from which to derive iPS cells for study. Also,
reprogramming of frozen tissues to derive iPS cells
can be processed together in one experiment in order
to minimize scientiﬁc variability and enhance exper-
imental consistency compared to individual experi-
ments performed multiple times on freshly harvested
tissues.
The other potentially useful application of
‘‘delayed’’ iPS cell reprogramming would be for the
archiving of genetically-altered mutant mouse lines.
Today, most mouse repositories archive frozen
germplasm as an alternative to storing and maintain-
ing mice as live breeding colonies ‘‘on the shelf’’.
Cryopreservation of embryos is considered the gold
standard for maintaining a frozen archive of mutant
mouse lines, but the process is lengthy, costly, and
laborious. Cryopreserving sperm is simpler, faster,
and cheaper, but some strains, notably C57BL/6 in
widespread use today, may not be viable for in vitro
fertilization (IVF) due to poor post-thaw recovery of
sperm motility and would require the use of intracy-
toplasmic sperm injection (ICSI) to recover the
mouse line. Frozen ES cells can be thawed and
injected into blastocysts to generate chimeric mice,
but germline transmission of a mutant allele is not
guaranteed. Further, except for ovaries, whole frozen
tissues and organs generally are not viable after
thawing. Nonetheless, small sections of tissues, such
as tail tips, and ﬁbroblasts isolated from them, can be
readily collected, quickly and easily frozen, and
maintained in cryostorage for minimal cost. In
addition, cryopreserved tissues could serve as a
viable backup to other cryopreserved formats, and
provide an abundant supply of somatic cells from
which iPS cells could be derived. Further, frozen
tissues are easily distributed to and shared among
researcher laboratories. Unfortunately, there are no
published studies establishing the effectiveness and
efﬁciency of reprogramming frozen-thawed somatic
tissues to derive iPS cells that can subsequently be
microinjected into blastocysts to produce chimeric
embryos that give rise to germline-competent live
mice.
Therefore, the purpose of this study was to
determine the feasibility of using frozen-stored-
thawed somatic cells and tissues as a means to
archive and maintain mutant mouse lines for distri-
bution. To test this, our ﬁrst aim was to determine the
efﬁciency of deriving viable iPS cells by retroviral
transfection of frozen-stored-thawed ﬁbroblasts with
three transcription factors: Oct3/4, Sox2 and Klf4.
Our second aim was to compare the effectiveness of
deriving iPS cells from frozen mouse tails and tail-
derived ﬁbroblasts. Our third aim was to determine
the reliability of using derived iPS cells to generate
chimeric mice that transmit a exogenously introduced
transgene through the germline to subsequent
generations of mice.
Materials and methods
Preparation of tail ﬁbroblasts
DsRED transgenic male mice at around 4 weeks old
were purchased from Jackson laboratory. To prepare
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1231 week frozen tail, tails (4–5 cm) were harvested and
rinsed with PBS several times. Afterwards the
superﬁcial dermis was removed. The tails were cut
into 1 cm pieces and were placed into cryogenic vials
(polypropylene, Nunc, Denmark) containing freezing
solution (PBS supplemented with 5% DMSO).
Groups of tails were kept in freezing solution at
-20C until frozen and then at -80C overnight. The
next day, frozen tail tissues were placed in liquid
nitrogen for 1 week storage, after which they were
thawed in a 37C water bath until ice was fully
melted. The tail was rinsed with ﬁbroblast medium
[DMEM medium (Invitrogen) supplemented with
10% fetal bovine serum (Hyclone), 2 mM L-gluta-
mine (Invitrogen), 1 mM sodium pyruvate (Invitro-
gen), and 100 U and 100 lgm l
-1 of penicillin and
streptomycin (Invitrogen). Tail pieces were placed in
a six well plate and were incubated in ﬁbroblast
medium at 37C. After 5 days, tail pieces were
discarded and the ﬁbroblasts were continuedin culture
until they reached 90% conﬂuency. Then 8 9 10
5
ﬁbrobalsts were taken for retroviral infection.
To prepare 1 month frozen ﬁbroblasts, ﬁbroblasts
derived from fresh tail were grown in a six well
plate for 6–7 days. They were harvested with 0.05%
trypsin (Invitrogen) and were plated onto 10 cm
culture dish. After 3–4 days, ﬁbroblasts were har-
vested with trypsin and were stored (8 9 10
5 cells/
vial) in freezing solution (ﬁbroblast medium supple-
ment with 20% fetal bovine serum plus 10% DMSO)
and frozen and stored as previously described, except
this group was stored for 1 month.
Retroviral infection
The retroviral vectors (pMXs-Sox2, pMXs-Oct3/4
and pMXs-Klf4) were obtained from Addgene (Cam-
bridge, MA). They were introduced into Plat-E cells
(Cell Biolabs, Inc.) using FuGENE 6 transfection
reagent (Roche). Twenty-seven microlitre of trans-
fection reagent was added to DMEM medium and
incubated at room temperature for 5 min. Nine
microgram of retroviral vector was added to this
transfection mixture for 30 min at room temperature.
After incubation, the DNA mixture was added to the
8 9 10
6 Plat-E cells (a derivative of 293 T cell
line for retrovirus packaging) in 10 cm culture dish.
The Plat-E cells were incubated at 37C with 5% CO2
for overnight. The next day, the medium was
discarded, and fresh medium was added for another
overnight incubation. Fibroblasts were seeded at
8 9 10
5 cells in a 10 cm culture dish coated with
mitomycin C-treated STO feeders. After overnight
culture, the retrovirus containing medium was ﬁltered
through a 0.45 lm cellulose acetate ﬁlter (Cole-
Parmer), polybrene was added to this medium to
achieve ﬁnal concentration equal to 4 lg/ml. Then,
the retrovirus containing medium was transferred to
the 10 cm culture dish containing ﬁbroblasts for
transfection. After overnight incubation, the medium
was replaced with fresh medium. Three days later,
regular LIF containing ES cell medium was used to
culture ﬁbroblasts until visible iPS clones had been
formed at around 2–3 weeks.
Examination of the iPS cells
Alkaline phosphatase staining
iPS cells were placed in 24-well culture plates and
grown till conﬂuent. The cell medium was aspirated
and the iPS cells were washed by 19 PBST (1XPBS
containing 0.05% Tween-20) brieﬂy and ﬁxed in
ﬁxing solution (Cell Biolabs, Inc) for 2 min. The
ﬁxing solution was discarded and the cells were
washed with 1XPBST twice. The Stem
TM TAG AP
staining solution (Cell Biolabs, Inc) was added to
the cells for incubation at room temperature and
protected from light. The desired brownish color on
the cell surface could be observed in 1–2 h under
the microscope if there was alkaline phosphatase
activity.
Immuno-staining analysis
Cells were washed brieﬂy with PBS and then ﬁxed
with 4% paraformaldehyde for 20 min. Then, the
cells were washed three times with PBS for 5 min
each. 0.3% H2O2 solution was added to the cells for
quenching endogenous peroxidase activity for 30 min
following by washing the cells three times with PBS
for 5 min each. The cells were incubated with the
blocking solution (10% goat serum) for 30 min and
then with the SSEA1 antibody (Abcam) in 1:300
dilution for 3 h. Staining was performed using the
Vectastain ABC kit (Vector Laboratory) according to
the manufacturer’s recommendations.
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Cells were cultured for 2–3 days for metaphase
preparation before harvesting. Chromosomes were
dispersed by incubation with KARYO MAX colce-
mid solution (Gibco) for 1 h, 0.56% KCl for 5 min
and re-suspended in methanol:glacial acetic acid
(3:1) ﬁxative solution. Cells were ﬁnally stained with
VECTASHIELD Mounting Medium with DAPI
(Vector Laboratory) on the slide and chromosomes
were counted.
Generation of chimeras and PCR genotyping
Two iPS cell clones from each treated group (i.e.,
1 week frozen tail and 1 month frozen ﬁbroblasts)
were taken for blastocyst microinjection. Chimeras
were produced by injecting iPS cells into 30–48
blastocysts harvested from 4 week old Balb/C
females. The injected blastocysts were transferred
into the uterus of pseudopregnant CD1 females. The
male chimeras with high iPS cell contribution were
crossed with CD1 females to identify germline
transmission of the DsRED transgenic allele. F1
offspring were examined for germline transmission
by their coat color and were conﬁrmed by PCR
ampliﬁcation of DsRED transgene using the follow-
ing primers: DsRED-F (50-CCCCGTAATGCAGA
AGAAGA-30) and DsRED-R (50-GGTGATGTCCA
GCTTGGAGT-30) and by DsRED expression.
Results
Generation of iPS cells from frozen tail tissue
and frozen ﬁbroblasts
We reprogrammed ﬁbroblasts isolated from tail snips
that were harvested from 4 week old DsRED trans-
genic mice (Vintersten et al. 2004) to derive iPS cells
for the generation of live chimeric mice and then
tested germline transmission of the mutant allele.
Fibroblasts migrating out from frozen-thawed tail
snips exhibited viability, rate of growth, and mor-
phological characteristics similar to those from
fresh cultured tail snips (Fig. 1). After that, fresh
tail-derived ﬁbroblasts, 1 week frozen-thawed tail-
derived ﬁbroblasts and 1 month frozen ﬁbroblasts
were transfected with retroviral vectors expressing
three transcription factors (Oct3/4, Sox2 and Klf4).
At approximately 20 days after transfection of cells
and growth in ES cell medium containing fetal calf
serum plus leukemia inhibitory factor (LIF), multiple,
morphologically discernable ES-like colonies were
observed (Fig. 2).
In one 10 cm dish for each group, 41, 38, and 15
distinct clones were observed, picked and expanded
from cells cultured from fresh tail, 1 week frozen-
thawed tail, and 1 month frozen-thawed ﬁbroblasts
(Table 1). These results indicate that ﬁbroblasts
obtained from frozen tail tissues are as suitable as
fresh tail tissues for the generation of clonal ES cell-
like clonal populations of cells. While the smaller
number of viable clones from 1 month frozen ﬁbro-
blasts suggests that prolonged storage of intact
somatic tissues at ultra-low temperatures may be
detrimental and reduce the efﬁciency of reprogram-
ming. Thus, while the feasibility of deriving iPS cells
from frozen-thawed tissues was the priority of this
study, the impact of storage conditions, such as
duration and temperature of storage, is an important
focus of future studies.
Identiﬁcation of DsRED iPS cells
Testing for ES cell-like cell surface marker
and enzymatic activity
In order to identify potential iPS cells with charac-
teristics equivalent to ES cells, the expression of cell
surface markers was examined by in vitro assays. It is
well established that undifferentiated mouse ES cells
express the speciﬁc cell surface epitope SSEA1
(Solter and Knowles 1987) and alkaline phosphatase
activity (Wobus et al. 1984). Strong alkaline phos-
phatase activity was measured in all clonal cells from
frozen-thawed ﬁbroblasts and tail-derived ﬁbroblasts
that maintained ES cell-like morphological charac-
teristics after propagating several passages in culture.
There were also cells staining positive for SSEA1
(Fig. 3a, b). Further, a high percentage of cells
showed both strong alkaline phosphatase activity and
SSEA1 marker expression (Table 2), consistent with
undifferentiated and pluripotent ES cell-like iPS
cells.
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and derivation of germline chimeras from DsRED
iPS cells
One test to deﬁnitively conﬁrm the pluripotency of
iPS cells is to derive chimeric mice which can be
analyzed for germline transmission of the mutant
allele. To do this, we ﬁrst assessed the chromosome
count of alkaline phosphatase-positive/SSEA1 posi-
tive iPS cells from frozen-thawed tail-derived ﬁbro-
blasts and frozen-thawed ﬁbroblasts (Fig. 4a). Of
these, iPS cells shown to be at least 80% diploid were
microinjected into the blastocoel cavity of Balb/C
derived blastocysts (8–12 cells/blastocyst) and trans-
ferred into the uterine horn of pseudopregnant CD-1
female foster mothers (Table 3). Chimeric mice were
generated from both groups of iPS cells, as evidenced
by expression of the transgenic red ﬂuorescent
protein (Fig. 4b). Chimeric male mice with high
contribution of DsRED iPS cells (Fig. 4c) were
crossed with wild-type CD1 females. Mice in the F1
mice showed black (C57BL/6) or agouti (C57BL/
6;CD1) coat color, besides, they all contained the
DsRED transgene when examination by PCR
(Fig. 5), further conﬁrming germline transmission
of an induced, mutant allele. These results conﬁrmed
that iPS cells derived from frozen-thawed ﬁbroblasts
and tail-derived ﬁbroblasts were pluripotent and thus
able to give rise to normal mice of the expected
genotype. Also, in term of number of chimeric mice
generated, there seems to have insigniﬁcant differ-
ence in efﬁciency between the group of 1 month
frozen-thawed ﬁbroblasts and 1 week frozen-thawed
tail-derived ﬁbroblasts (Table 3).
Discussion
The results of our study have three implications. First,
mouse ﬁbroblasts derived from frozen tail tissue or
Fig. 1 Propagation of ﬁbroblasts from mouse tail tissue. Morphology of tail ﬁbroblasts from the culture of fresh tissue, 1 week
frozen tail (FT) and 1 month frozen ﬁbroblasts (FF). Magniﬁcation 94. Scale bar = 200 lm
Fig. 2 iPS cell colonies formation by transfection of three
transcription factors (Oct3/4, Sox2 and Klf4). Around 20 days
after transfection, ﬁbroblasts were reprogrammed to form iPS
cell colonies from fresh tail tissue (Fresh), 1 week frozen tail
(FT) and 1 month frozen ﬁbroblasts (FF). Magniﬁcation 94.
Scale bar = 200 lm
Table 1 iPS cells derived from freshly harvested and 1 week
and 1 month frozen stored tail tissues
Source tissue No. of expandable iPS
cell clones
Fresh tail 41
1 week frozen tail 38
1 month frozen ﬁbroblast 15
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reprogrammed into iPS cells. Viable ﬁbroblasts can
be retrieved from frozen storage in freezing solution
supplemented with DMSO. DMSO is a well known
cryoprotectant, which is essential to prevent cryo-
damage and cell degeneration (Lovelock and Bishop
1959; Wood et al. 1993). The use of DMSO has been
shown to preserve cells suitable for nuclear transfer
(Fahrudin et al. 2001). Also, three transcription
factors (Sox2, Oct3/4 and Klf4) not including c-
myc are sufﬁcient for successful reprogramming of
frozen ﬁbroblasts. It has been shown that there is a
direct molecular interaction between Klf4 and Oct4
and Sox2 which is crucial for efﬁcient somatic cell
reprogramming (Wei et al. 2009). Further, reactiva-
tion of c-myc retrovirus is implicated in tumor
formation in iPS cell-derived mice (Okita et al.
2007). Therefore, it was important in our study to
demonstrate that iPS cells to be used to derive live
mice could be generated in the absence of c-myc.
Recent studies have used transposon technology to
derive transgene-free iPS cells, which further reduces
the risk of genetic mutation and transgene reactiva-
tion (Wang et al. 2008; Yusa et al. 2009).
Secondly, tail tissues and tail-derived ﬁbroblasts
are easy to obtain, simple to preserve, and cost-
effective to store frozen, thus providing a nearly
Fig. 3 Testing the identity of the iPS cell by molecular
markers. The iPS cells that derived from frozen tail (FT)/
ﬁbroblasts (FF) had strong alkaline phosphatase activity (a)
and had strong expression of mouse ES cell surface marker
SSEA1 (b). They showed similar expression pattern as the
C57BL/6J wild type (WT)ES cells. Magniﬁcation 920. Scale
bar in panel a and b, 50 lm
Table 2 Alkaline phosphatase activity and SSEA1 immuno-
stainng for iPS cells
Source tissue No. of iPS
cell clones
No. (%) of iPS cell
clones immunopositive for
both AP andSSEA1
1 week
frozen tail
38 31 (70.5)
1 month frozen
ﬁbroblast
15 11 (73.5)
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time in the future. The efﬁciency of the process is
supported by the fact that, at least for short-term
storage, the number of iPS clones from frozen tail
was comparable to that from fresh tail. This is likely
because ﬁbroblasts that migrate out from frozen-
thawed tail divide and regenerate new ﬁbroblasts like
those from fresh tail, thus promoting efﬁcient repro-
gramming. Although not directly studied, this sug-
gests that reprogramming of frozen ﬁbroblasts
transfected soon after thawing will be less efﬁcient
than after several days in culture, as the freeze–thaw
Fig. 4 DsRed iPS cells obtained from 1 week frozen tail (FT)
and 1 month frozen ﬁbroblasts (FF) were taken for blastocyst
injection. a iPS clones expanded in standard ES cell medium
were predominantlyeuploid. b These iPS cells were able to
generate chimeric pups with red ﬂuorescent protein (RED)
expression. c The chimeras with high chimerism and RED
expression were taken for germline testing
Table 3 Summary of blastocyst injections
Source tissue Cell line No. blastocysts
injected
No. chimeras
(% injection)
Chimerism (%) Germline
transmission
1 week frozen tail FT-4B 24 3 (12.5) 40–90 Yes
FT-5B 24 3 (12.5) 40–80 Yes
1 month frozen ﬁbroblast FF-2E 31 4 (12.9) 40–90 Yes
FF-8E 22 3 (13.6) 10–80 Yes
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otherwise non-viable cells. However, our data sug-
gests that reprogramming may be less efﬁcient on
frozen-thawed cells obtained from tissues after pro-
longed ultra-cold storage. Future studies are needed
to determine the role of storage conditions on the
ability to derive iPS cells from frozen tail as well as
other somatic tissues.
Thirdly, our data conﬁrms that iPS cells derived
from frozen tail and tail-derived ﬁbroblasts are
sufﬁciently pluripotent to contribute to the germline.
This is important because it supports the contention
that frozen tissues and cells can be used as an
alternative to ES cells and germplasm for the
cryopreservation of mutant mouse lines. To our
knowledge, this is the only publication demonstrating
that iPS cells derived from frozen tissues and cells
can be used to reanimate an entire animal, and not
just a few speciﬁc cell types and/or organs. For
example, in an earlier study, that cyropreserved
human primary dermal ﬁbroblasts could be repro-
grammed into iPS cells, but they were subsequently
differentiated only into haematopoietic progenitors
(Raya et al. 2009). Our study extends these early
results by demonstrating that iPS cells from frozen
tissues and cells can differentiate into a variety of
tissues, most importantly germ tissues (sperm) that
can give rise to subsequent generations of mice.
Recently, viable, fully iPS cell-derived mice have
been generated by tetraploid complementation of
fresh cells (Kang et al. 2009; Zhao et al. 2009;
Boland et al. 2009), although our results suggest that
similar results could be obtained using frozen-thawed
cells. Further, we demonstrated that iPS cells derived
from frozen tissue and cells do not lose their
pluripotency. Therefore, together these results sug-
gest that fully cloned animals can be reconstituted
from tissues and/or cells that have been frozen and
maintained viable in storage.
We demonstrate here for the ﬁrst time that frozen
tail tissues and frozen tail-derived ﬁbroblasts can be
reprogrammed into iPS cells which retain pluripo-
tency, contribute to the germline, and generate
chimeric mice that transmit a transgene through the
germline. Tissues and ﬁbroblasts are easy to obtain
from mice, and are simple, fast, and cost-effective to
maintain in frozen storage. Therefore, cryopreserva-
tion of somatic tissues and/or cells is a viable method
for ensuring a reliable and steady source of cells for
the conversion of somatic tissues into embryos, and
the reanimation of frozen stocks into live mice
through generation of iPS cells.
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